Forbion Capital Partners Management Holding BV

Forbion Capital Partners Management Holding BV

Forbion Capital Partners Management Holding BV

Overview
Date Founded

2007

Headquarters

Gooimeer 2-35,Naarden, Noord-Holland 1411 DC

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Private Equity & Venture Capital
Hospitals & Patient Services
Biotechnology
Investment Services & Portfolio Management

Company Description

Forbion is an active manager which invests in life sciences and biomedical technology companies in Northwest Europe and the US. The firm focuses on companies that have innovative technologies and drug development programs. In Europe, Forbion tends to take the lead investor role, while in the US they prefer to be a co-lead investor, making initial investments ranging from EUR 1 - EUR 7 million, and participates in follow-on investments. Forbion generally takes a seat on the board of directors.

Website

http://www.forbion.com

Contact Data
Trying to get in touch with decision makers at Forbion Capital Partners Management Holding BV? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
ENP Newswire
December 11, 2020
-Lonza, Forbion and BioGeneration Ventures Announce Collaboration for Development and Manufacture of Biologics for Portfolio Companies
PR Newswire
November 19, 2020
SynOx Therapeutics raises €37M in Series A Financing; - HealthCap and Medicxi co-lead, joined by Forbion and Gimv
GlobeNewswire
November 10, 2020
CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients
Business Wire
October 7, 2020
Forbion Portfolio Company, Enterprise Therapeutics' First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by Roche
Business Wire
September 8, 2020
Inversago Pharma Closes US$35M Series B Financing Round and Expands Board of Directors; Funds to pursue development of INV-101 and other promising peripheral CB1 blockers to clinical proof-of-concept, as well as to expand the Company's operations.; Board

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Sander Slootweg

Co-Founder

Geert-Jan Mulder

Co-Founder

Martien van Osch

Managing Partner

Marco Boorsma

General Partner

Holger N. Reithinger

General Partner

Dirk Kersten

General Partner

Patrick Michael Round

Venture Partner

Juliette Audet

Partner

Wouter Joustra

Partner

Philip Astley-Sparke

Venture Partner

Trending People
Manchester United Limited
Women's Super League highlights: Sam Kerr & Beth England fire Chelsea to West Ha... - BBC
3M Innovative Properties Co.
U.S. Patents Awarded to Inventors in Texas (March 6) - Targeted News Service
Federal Emergency Management Agency
FEMA vaccine site abandoned state rules, gave vaccine to any resident 18 and ove... - The Miami Herald
United States Department of Agriculture
USDA relocations curtail ag research, farmer confidence - The Independent UK
Democratic Party
Rising Mich. Dem star's 2 paychecks could pose a conflict - Detroit Free Press
Trending Organizations
Manchester United Limited
Women's Super League highlights: Sam Kerr & Beth England fire Chelsea to West Ha... - BBC
3M Innovative Properties Co.
U.S. Patents Awarded to Inventors in Texas (March 6) - Targeted News Service
Federal Emergency Management Agency
FEMA vaccine site abandoned state rules, gave vaccine to any resident 18 and ove... - The Miami Herald
United States Department of Agriculture
USDA relocations curtail ag research, farmer confidence - The Independent UK
Democratic Party
Rising Mich. Dem star's 2 paychecks could pose a conflict - Detroit Free Press
Paths to Forbion Capital Partners Management Holding BV
Potential Connections via
Relationship Science
You
Forbion Capital Partners Management Holding BV
Recent Transactions
Details Hidden

Roche Holding AG purchases Promedior, Inc. from HealthCare Ventures LLC, Polaris Partners, Easton Capital Investment Group, Forbion Capital Partners Management Holding BV, Morgenthaler Management Corp., BioMed Ventures

Details Hidden

Edwards Lifesciences Corp. purchases Mitralign, Inc. from Oxford Bioscience Partners, Giza Venture Capital, Orchestra Medical Ventures LLC, Triathlon Medical Venture Partners LLC, Forbion Capital Partners Management Holding BV, Palisade Capital Management (Private Equity)

Details Hidden

Bio-Techne Corp. purchases Exosome Diagnostics, Inc. from NGN Capital LLC, Forbion Capital Partners Management Holding BV, Julip Run Capital LLC, btov Partners AG

Transaction Advisors
Legal Advisor
Goodwin Procter LLP

Advised onAmgen, Inc. purchases BioVex Group, Inc. from Scottish Equity Partners LLP, Kreos Capital Management (UK) Ltd., Lloyds Development Capital (Holdings) Ltd., MVM Partners LLP, Ventech SA, Beringea LLP, IPSA SAS, Avalon Ventures Management LLC, GeneChem Management, Inc., New Science Ventures LLC, Morningside Group Ltd., Triathlon Medical Venture Partners LLC, 180 Degree Capital, Omnes Capital SAS /Venture, Forbion Capital Partners Management Holding BV, Ysios Capital Partners SGEIC SA, Sectoral Asset Management Inc (Private Equity)

Legal Advisor
Hogan & Lovells LLP

Advised onAmgen, Inc. purchases Dezima Pharma BV from New Science Ventures LLC, Forbion Capital Partners Management Holding BV, Biogeneration Management BV

Escrow Agent
JPMorgan Chase Bank, NA (Investment Management)

Advised onBio-Techne Corp. purchases Exosome Diagnostics, Inc. from NGN Capital LLC, Forbion Capital Partners Management Holding BV, Julip Run Capital LLC, btov Partners AG

Investments
Details Hidden
Gotham Therapeutics Corp.

Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY.

Details Hidden
Achilles Therapeutics Ltd.

Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.

Details Hidden
Catalym GmbH

CatalYm GmbH specializes in catalyzing immunotherapy. The company is headquartered in Munich, Germany.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Forbion Capital Partners Management Holding BV. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Forbion Capital Partners Management Holding BV's profile does not indicate a business or promotional relationship of any kind between RelSci and Forbion Capital Partners Management Holding BV.